top of page

Houston Oncology Summit: MD Anderson Professor of Immunology Michael Curran talks turning cold tumors hot, including work by his company ImmunoGenesis

He discusses pathways that could play a role in helping solve this problem, including combinations with ADCs, STING and CD47, and work by his company ImmunoGenesis on a PD-L1/PD-L2 inhibitor



Brought to you by:



Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

SAV_Logo_2024.png

At Savills, the Life Sciences Team specializes in helping biotech companies unlock their full potential by aligning real estate strategies with their scientific and business goals. As a leading global commercial real estate advisory firm, we focus exclusively on occupier services and tenant representation, acting as a trusted partner to some of the most innovative companies in the industry.

bottom of page